Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750706
Max Phase: Preclinical
Molecular Formula: C28H37N9O8S
Molecular Weight: 659.73
Molecule Type: Unknown
Associated Items:
ID: ALA4750706
Max Phase: Preclinical
Molecular Formula: C28H37N9O8S
Molecular Weight: 659.73
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)Nc1cc(NC(=O)CCCN)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1
Standard InChI: InChI=1S/C28H37N9O8S/c29-10-4-9-23(38)34-18-12-17(13-19(14-18)35-28(30)31)25(40)33-16-24(39)32-15-21(27(42)43)36-26(41)22-8-5-11-37(22)46(44,45)20-6-2-1-3-7-20/h1-3,6-7,12-14,21-22H,4-5,8-11,15-16,29H2,(H,32,39)(H,33,40)(H,34,38)(H,36,41)(H,42,43)(H4,30,31,35)/t21-,22-/m0/s1
Standard InChI Key: MGRPJUCLIBBWKX-VXKWHMMOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 659.73 | Molecular Weight (Monoisotopic): 659.2486 | AlogP: -1.06 | #Rotatable Bonds: 15 |
Polar Surface Area: 279.00 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.04 | CX Basic pKa: 10.03 | CX LogP: -4.62 | CX LogD: -5.88 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.08 | Np Likeness Score: -1.19 |
1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H. (2020) Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness., 30 (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578] |
Source(1):